Rafael Holdings Q1 fiscal 2024 net loss narrows to $3.8M from $5.2M YoY

Rafael Holdings, Inc.

2024-Q1 EPS reported -$0.16 revenue$68,000

Net loss from continuing operations of $3.8M ($0.15/share) vs $5.2M ($0.22/share) a year ago.
Cash, cash equivalents and marketable securities of $72.1M as of Oct 31, 2023.
R&D expenses fell to $0.5M from $2.1M, driven by winding down early-stage programs.
G&A expenses decreased to $2.0M from $3.1M due to lower stock-based compensation and payroll.
CEO says company advancing portfolio and seeking strategic investments; continues supporting Cyclo Therapeutics (CYTH).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Rafael Holdings, Inc. reported first quarter of fiscal 2024 - the three months ended October 31, 2023 results: net income net loss from continuing operations of $3.8 million, or $0.15 per share, EPS $0.15 per share.

Period: first quarter of fiscal 2024 - the three months ended October 31, 2023
Net income: net loss from continuing operations of $3.8 million, or $0.15 per share
EPS: $0.15 per share
Result: reported results

Exact text from the filing

Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results

View on SEC.gov

Browse all earnings releases →

Rafael Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-095718

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.